Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opana ER in Opioid-Experienced Chronic Low Back Pain
NCT00226421Phase 3Completed
- Sponsor
- Endo International plc
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic low back pain (CLBP) comparing Opana ER with Placebo (2 arms). Primary endpoint: Change in pain intensity from baseline to last assessment. Started Oct 2004; status: completed.
02
Drugs
oxymorphone
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT00226421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226421.